Medscape

FDA OKs First Adaptive DBS System for Parkinson’s Disease

The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual brain activity in ...
The American Journal of Managed Care

Adaptive Deep Brain Stimulation Technology Receives FDA Approval for Parkinson Disease

The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...
Nasdaq

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...
Tech Times on MSN

Deep brain stimulation activates hidden astrocyte gene programs in human tissue study

Deep brain stimulation researchers at UCLA and UT Southwestern published a Nature study mapping, for the first time in living ...